Prelude Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$1.67M 1441
2024
Q4
$1.67M Buy
+10,000
New +$1.78M 0.1% 224
2021
Q1
Sell
-35,000
Closed -$2.26M 1743
2020
Q4
$2.26M Sell
35,000
-900
-3% -$53.6K 0.06% 260
2020
Q3
$2.14M Buy
35,900
+900
+3% +$51.1K 0.1% 147
2020
Q2
$1.93M Buy
+35,000
New +$1.85M 0.11% 169
2020
Q1
Sell
-42,500
Closed -$2.25M 1870
2019
Q4
$2.25M Buy
+42,500
New +$2.34M 0.09% 187
2019
Q2
Sell
-27,500
Closed -$1.48M 2026
2019
Q1
$1.48M Buy
+27,500
New +$1.4M 0.08% 250
2018
Q4
Sell
-25,500
Closed -$1.31M 2059
2018
Q3
$1.31M Buy
+25,500
New +$1.24M 0.08% 291
2014
Q3
Sell
-10,000
Closed -$405K 2056
2014
Q2
$405K Buy
+10,000
New +$411K 0.05% 459

Other funds holding ORCL

Prelude Capital Management's ORCL Position: Q1 2026 in Review

Prelude Capital Management reduced its Oracle (ORCL) stake by 11% in Q1 2026, selling an estimated $147K and leaving 7,173 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #293.

Prelude Capital Management first reported a position in ORCL in Q2 2013 and has held it in 30 quarters since. The position peaked at $6.65M in Q1 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Prelude Capital Management held 7,173 shares of Oracle worth $1.05M as of Q1 2026.
  • Prelude Capital Management sold 905 Oracle shares in Q1 2026, an estimated $147K.
  • Oracle made up 0.08% of Prelude Capital Management's portfolio in Q1 2026, its #293 holding.
  • Prelude Capital Management first reported a position in Oracle in Q2 2013 and has held it in 30 quarters since.
  • Prelude Capital Management's Oracle position peaked at $6.65M in Q1 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.